MyFinsight
Home
About
Contact
Back
Income Statement
TScan Therapeutics, Inc. (TCRX)
source: myfinsight.com
Download
Download image
Interest and other
income, net
$2,390K
Net loss
-$36,952K
Total other income
$1,701K
Interest expense
$689K
Loss from operations
-$38,653K
Collaboration and license
revenue
$3,076K
Total operating
expenses
$41,729K
General and
administrative
$9,095K
Research and development
$32,634K
Back